Asia Raises Bar for New Drugs, Manufacturers
With Tougher CMC Reviews, GMP Inspections

As Asian drug regulatory authorities gain confidence in their ability to regulate new drug products, they are subjecting applicants to increasingly extensive chemistry, manufacturing and controls reviews, more like those of first-tier authorities in the U.S. and Europe.